- $3.30bn
- $5.09bn
- $9.25bn
- 94
- 93
- 89
- 100
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,364 | 3,930 | 7,242 | 10,896 | 9,247 |
Cost of Revenue | |||||
Gross Profit | 980 | 79 | 218 | 1,130 | 1,273 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5,784 | 4,263 | 7,147 | 10,012 | 8,124 |
Operating Profit | 580 | -333 | 95 | 884 | 1,123 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 491 | -415 | 66 | 801 | 1,085 |
Provision for Income Taxes | |||||
Net Income After Taxes | 362 | -320 | 74 | 644 | 878 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 380 | -256 | 25 | 463 | 769 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 380 | -256 | 25 | 463 | 769 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.75 | -2.24 | 0.216 | 5.33 | 5.74 |
Dividends per Share | |||||
Special Dividends per Share |